B cell lymphoma-2-like protein 11 (known as BIM) deletion polymorphism [33] and differential protein stability [34] are related to the outcomes of ALK-TKIs on a molecular basis, while PLR can predict the prognosis of patients with ALK-positive NSCLC [28]. This evidence concerns the gene ALK and non-small cell lung carcinoma.